Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Noc Stock Analysis Northrop Grumman Gains 0.79 Pct To 702.5 Amid Defense Demand 20260403 1 Is Elanco Elan Stock A Buy Or Sell Price At 22.86 Down 0.95 20260406 Is Sphere Entertainment Sphr Stock Slowing Down Price At 127.40 Up 0.14 20260406 Is Chegg Chgg Stock A Future Winner Price At 0.87 Up 9.00 20260413 Raspberry Pi CEO Warns AI Skepticism May Deter Tech Talent Risk Economic Growth Warren Buffetts Tiny Purchase in March Potentially Revealed in Latest Berkshire Filing Isabella ISBA Q4 2025 Results Fall Short EPS 583 Revenue NA SBA SBAC Holds 20159 Direction Awaited 20260515 Cardlytics CDLX Crushes Q1 2026 Estimates EPS 011 Tops Views Nasdaq NDAQ Q1 2026 Earnings 096 EPS Surges Past 095 Estimates CNBC Unveils 2026 Disruptor 50 AI Companies Dominate Rankings as a New Leader Emerges IZEA Worldwide IZEA Climbs 131 Resistance at 407 in Focus 20260518 Amazon UK Chief Urges Shift in Blaming Youth for Unemployment Points to Education System Gaps Applied Digital Signs Major Hyperscaler Lease at Polaris Forge 3 Campus What It Means for Growth Trainline Lifts FullYear Guidance for Second Time This Year Signaling Continued Market Confidence Harvard Universitys Crypto Sales Q1 Portfolio Rebalancing Sparks Market Questions Oil Prices Decline for the Week as USIran Talks Show Progress Key Differences Remain Dont Let Tax Savings Dictate Retirement Moves Hidden Costs of NoIncomeTax States MIAX Q1 2026 Earnings EPS Surpasses Estimates by 98 Amid Stable Operations GECC Q1 2026 Earnings EPS Beats Estimates by 126 Amid Stable Operations AVGO Q1 2026 Earnings A Slight EPS Miss Amidst Solid Operational Momentum NTIC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment AVNS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction Blackstone Strategic Credit 2027 Term Fund BGB Holds Steady at 1134 as Market Waits for Catalysts DiaMedica Therapeutics DMAC Gains 4 as Stock Approaches Key Resistance Level 60 Degrees Pharmaceuticals SXTP Holds Near Support After Minor Decline ResMed RMD Holds Steady Minor Decline Amidst RangeBound Trading